April 21, 2014 4:12 AM ET


Company Overview of Tokai Pharmaceuticals, Inc.

Executive Profile

Philip W. Kantoff M.D.

Chief Clinical Research Officer and Member of Medical Advisory Committee, Tokai Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 6 different industries.

See Board Relationships


Dr. Philip W. Kantoff, M.D. serves as Chief Clinical Research Officer and a Member of Medical Advisory Committee of Tokai Pharmaceuticals, Inc. Dr. Kantoff has been Chief Clinical Research Officer at Dana-Farber Cancer Institute, Inc. since October 2006. He serves as Chief of Division of Solid Tumor Oncology and Leader of the Dana-Farber and Harvard Cancer Center Prostate Cancer Program. He is a Professor of Medicine in Harvard Medical School. He joined Dana-Farber in ...

Corporate Headquarters

One Broadway
Cambridge, Massachusetts 02142

United States

Phone: 617-225-4305
Fax: 617-902-2444

Board Members Memberships

There is no Board Members Memberships data available.


Unknown/Other Education 1979
Brown University Medical School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Tokai Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.